One year open follow-up to study; Effect of one year treatment with budesonide Turbuhaler and nedocromil pMDI with spacer on bone mineral density, physical activity, and lung function in newly diagnosed asthmatic children.

Study identifier:SD-004-3064B

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

One year open follow-up to study; Effect of one year treatment with budesonide Turbuhaler and nedocromil pMDI with spacer on bone mineral density, physical activity, and lung function in newly diagnosed asthmatic children.

Medical condition

asthma

Phase

N/A

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

-

Age

-

Date

Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria